American Oriental Bioengineering, Inc. (OTCPK: AOBI)
Consumer Staples · Personal Care Products · CN
$0.01
— today · +1081.8% 1Y
American Oriental Bioengineering, Inc. (OTCPK: AOBI) operates in the Personal Care Products industry within the Consumer Staples sector. The company is valued at $949.00 and employs 3,719 people.
Over the last twelve months the share price has gained 1081.8%, trading between 0.00 and 0.01.
Tweenvest scores American Oriental Bioengineering, Inc. across four factors: quality 28/100, value 64/100. Its strongest factor is value.
AOBI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $949.00
- Revenue (TTM)
- $121.58M
- P/E
- —
- EPS
- -1,243.22
- Dividend yield
- —
- Beta (5Y)
- 0.05
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 72.99K
- Employees
- 3,719
- Next earnings
- —
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
- ISIN
- US0287315032
- Listed since
- Dec 12, 2001
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Personal Care Products companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| L'Oréal S.A.ENXTPA: OR | $243.83B | €388.50 | -1.02% |
| Unilever PLCLSE: ULVR | $140.50B | £47.62 | -0.44% |
| Hindustan Unilever LimitedNSEI: HINDUNILVR | $49.81B | Rs2,030.00 | +0.74% |
| The Estée Lauder Companies Inc.NYSE: EL | $37.67B | $103.95 | -0.17% |
| Kenvue Inc.NYSE: KVUE | $37.32B | $19.37 | -0.33% |
| Beiersdorf AktiengesellschaftXTRA: BEI | $20.68B | €80.30 | -1.21% |
| Kao CorporationTSE: 4452 | $20.29B | ¥3,567.00 | +0.31% |
| Puig Brands, S.A.BME: PUIG | $11.42B | €17.88 | +2.94% |
Figures last refreshed Aug 18, 2026.